IGC Pharma, Inc.
IGC Pharma, Inc. (IGC) Revenue
Annual & quarterly revenue history · segment & region breakdown
IGC · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsIGC Pharma, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income IGC Pharma, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
IGC Pharma, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from IGC Pharma, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
IGC revenue · 4 questionsIGC's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · IGC Pharma, Inc. SEC filings · GAAP · IGC Pharma, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026